{"nct_id":"NCT01200589","title":"Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy","status":"TERMINATED","status_verified_date":"2018-04","start_date":"2010-10-11","start_date_type":"ACTUAL","primary_completion_date":"2016-12-19","primary_completion_date_type":"ACTUAL","completion_date":"2016-12-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}